MOUNTAINEER: Tucatinib in combination with trastuzumab for HER2-positive mCRC

Working to improve global cancer care access in low middle-income countries

Updates from the PROpel and MAGNITUDE studies

Update on the latest in PARP inhibitors for prostate cancer

Isatuximab + Pd in Difficult-to-Treat Patients with RRMM

ASCO Direct Highlights 2022: prostate cancer highlights

ASCO Direct Highlights 2022: lung cancer highlights

Locally and advanced immunotherapy developments and new agents in lung cancer

The advances in the management of patients with Hodgkin lymphoma and non-Hodgkin lymphoma

New developments in the treatment of colorectal malignancies

Axicabtagene ciloleucel provides superior EFS vs standard of care in elderly with relapsed/refractory large B-cell lymphoma

Using combined oral contraceptives may decrease risk of Ovarian, Endometrial and Colorectal cancer